Lastly, the exploration of other genes implicated in the prognosis of colorectal cancer and their interplay with gene-drug polymorphisms, such as the TP53 and SMAD4 genes [56], remains a promising avenue for future research. This evidence concerns the gene TP53 and colorectal cancer.